Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 304,733 | 310,745 | 429,074 | 461,225 | 425,888 |
| Marketable Securities | 529,907 | 588,706 | 534,201 | 583,675 | 654,502 |
| Receivables | 22,756 | 27,058 | 27,852 | 24,241 | 23,946 |
| Inventories | 43,495 | 36,121 | 29,625 | 24,599 | 18,276 |
| TOTAL | $913,896 | $970,287 | $1,029,188 | $1,101,134 | $1,129,805 |
| Non-Current Assets | |||||
| PPE Net | 39,154 | 37,957 | 35,510 | 32,504 | 31,119 |
| Intangibles | 820,268 | 820,497 | 820,725 | 820,953 | 822,739 |
| Other Non-Current Assets | 45,631 | 47,401 | 51,243 | 52,379 | 50,492 |
| TOTAL | $905,053 | $905,855 | $907,478 | $905,836 | $904,350 |
| Total Assets | $1,818,949 | $1,876,142 | $1,936,666 | $2,006,970 | $2,034,155 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,853 | 12,883 | 17,607 | 11,002 | 4,960 |
| Accrued Expenses | 24,886 | 25,174 | 19,489 | 36,261 | 30,820 |
| Other current liabilities | 4,609 | 5,905 | 3,129 | 5,759 | 2,927 |
| TOTAL | $81,649 | $84,396 | $61,010 | $71,709 | $55,608 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 30,689 | 32,084 | 12,729 | 10,977 | 9,773 |
| Other Non-Current Liabilities | 1,108,947 | 1,108,033 | 1,115,832 | 1,119,225 | 1,119,293 |
| TOTAL | $1,110,709 | $1,109,860 | $1,141,078 | $1,144,274 | $1,137,740 |
| Total Liabilities | $1,192,358 | $1,194,256 | $1,202,088 | $1,215,983 | $1,193,348 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 226,109 | 224,841 | 224,383 | 221,183 | 220,598 |
| Common Shares | 226 | 225 | 224 | 221 | 221 |
| Retained earnings | -1,447,956 | -1,370,985 | -1,299,591 | -1,218,092 | -1,148,763 |
| Other shareholders' equity | -6,260 | -5,457 | -4,085 | -1,087 | 27 |
| TOTAL | $626,591 | $681,886 | $734,578 | $790,987 | $840,807 |
| Total Liabilities And Equity | $1,818,949 | $1,876,142 | $1,936,666 | $2,006,970 | $2,034,155 |